Sucralfate and Dermatitis exfoliative - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative is reported as a side effect among people who take Sucralfate (sucralfate), especially for people who are female, 60+ old, also take Colecalciferol, and have High blood pressure.

The phase IV clinical study analyzes which people have Dermatitis exfoliative when taking Sucralfate. It is created by eHealthMe based on reports of 17,187 people who have side effects when taking Sucralfate from the FDA, and is updated regularly.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

What is Dermatitis exfoliative?

Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 682 drugs and 945 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

17,187 people reported to have side effects when taking Sucralfate.
Among them, 11 people (0.06%) have Dermatitis exfoliative.

Could Sucralfate cause Dermatitis exfoliative?

Among these 11 people:

What is the gender of people who have Dermatitis exfoliative when taking Sucralfate? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Dermatitis exfoliative when taking Sucralfate? *

What are other drugs people take besides Sucralfate? *

What are other side effects people have besides Dermatitis exfoliative? *

Fever: 6 people, 54.55%
Thrombocytopenia (decrease of platelets in blood): 4 people, 36.36%
Haemoglobin Decreased: 4 people, 36.36%
Rash Pruritic (redness with itching): 3 people, 27.27%
Rashes (redness): 3 people, 27.27%
Itching: 2 people, 18.18%
White Blood Cell Count Decreased: 2 people, 18.18%
Rash Scaly: 2 people, 18.18%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 18.18%
Fatigue (feeling of tiredness): 1 person, 9.09%

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 18.18%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 9.09%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
Fever: 1 person, 9.09%
Erythema Multiforme (a type of hypersensitivity reaction): 1 person, 9.09%
Constipation: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sucralfate and have Dermatitis exfoliative?

- Check whether Dermatitis exfoliative is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sucralfate:

Sucralfate (17,548 reports)

Browse all side effects of Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (682 drugs)

Browse all the conditions that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (945 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sucralfate (the active ingredients of Sucralfate) and Sucralfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.